These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38097273)

  • 1. Long-lasting improvement of refractory antisynthetase syndrome with tocilizumab: a report of two cases.
    Baumann Benvenuti F; Dudler J
    RMD Open; 2023 Dec; 9(4):. PubMed ID: 38097273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisynthetase syndrome treated with tocilizumab.
    Beaumel A; Muis-Pistor O; Tebib JG; Coury F
    Joint Bone Spine; 2016 May; 83(3):361-2. PubMed ID: 26471411
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
    Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
    J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome.
    Marie I; Dominique S; Janvresse A; Levesque H; Menard JF
    Respir Med; 2012 Apr; 106(4):581-7. PubMed ID: 22280877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The successful use of tocilizumab as third-line biologic therapy in a case of refractory anti-synthetase syndrome.
    Murphy SM; Lilleker JB; Helliwell P; Chinoy H
    Rheumatology (Oxford); 2016 Dec; 55(12):2277-2278. PubMed ID: 27550295
    [No Abstract]   [Full Text] [Related]  

  • 6. Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
    Bozkirli DE; Kozanoglu I; Bozkirli E; Yucel E
    J Clin Apher; 2013 Dec; 28(6):422-5. PubMed ID: 23908096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisynthetase syndrome: not just an inflammatory myopathy.
    Chatterjee S; Prayson R; Farver C
    Cleve Clin J Med; 2013 Oct; 80(10):655-66. PubMed ID: 24085811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 65-year-old Woman With Persistent Dyspnea, Arthritis, and Raynaud's Phenomenon.
    Chong WH; Saha BK; Beegle S
    Am J Med Sci; 2021 Apr; 361(4):526-533. PubMed ID: 33386120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary manifestations in antisynthetase syndrome.
    Ben Salem T; Abdelkafi C; Lamloum M; Ben Ghorbel I; Houman MH
    Tunis Med; 2018 Feb; 96(2):101-106. PubMed ID: 30324974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jo1-antisynthetase syndrome and severe interstitial lung disease with organising pneumonia on histopathology with favourable outcome on early combined treatment with corticosteroids, mycophenolate mofetil and rituximab.
    Rüegg CA; Maurer B; Laube I; Scholtze D
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisynthetase Syndrome and Autoantibodies: A Literature Review and Report of 4 Cases.
    Marin FL; Sampaio HP
    Am J Case Rep; 2019 Jul; 20():1094-1103. PubMed ID: 31344020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review.
    Liu Y; Liu X; Xie M; Chen Z; He J; Wang Z; Dai J; Cai H
    Respir Med; 2020; 165():105920. PubMed ID: 32174452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical progressive multifocal leukoencephalopathy in a patient with antisynthetase syndrome.
    Belhassen-Garcia M; Rábano-Gutiérrez A; Velasco-Tirado V; Romero-Alegria A; Pérez-Garcia ML; Martin-Oterino JA
    Intern Med; 2015; 54(5):519-24. PubMed ID: 25758081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Treatment of Life-Threatening Interstitial Lung Disease Secondary to Antisynthetase Syndrome Using Rituximab: A Case Report and Review of the Literature.
    Dasa O; Ruzieh M; Oraibi O
    Am J Ther; 2016; 23(2):e639-45. PubMed ID: 25830868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of antisynthetase syndrome presenting as rhabdomyolysis with rituximab.
    Sabha MM; Simo HT; Shadid RM; Altorok NI
    Rheumatol Int; 2018 Jun; 38(6):1125-1130. PubMed ID: 29644434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review.
    Doyle TJ; Dhillon N; Madan R; Cabral F; Fletcher EA; Koontz DC; Aggarwal R; Osorio JC; Rosas IO; Oddis CV; Dellaripa PF
    J Rheumatol; 2018 Jun; 45(6):841-850. PubMed ID: 29606668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances.
    Hallowell RW; Danoff SK
    Curr Opin Rheumatol; 2014 Nov; 26(6):684-9. PubMed ID: 25203119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous immunoglobulins for the treatment of a patient with antisynthetase syndrome and secondary chronic immunodeficiency after anti-CD20 treatment: a case report.
    Cherin P; de Jaeger C; Crave JC; Delain JC; Tadmouri A; Amoura Z
    J Med Case Rep; 2017 Mar; 11(1):58. PubMed ID: 28257650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisynthetase syndrome: Analysis of 11 cases.
    Zamarrón-de Lucas E; Gómez Carrera L; Bonilla G; Petit D; Mangas A; Álvarez-Sala R
    Med Clin (Barc); 2017 Feb; 148(4):166-169. PubMed ID: 28073522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanics hands in patients with antisynthetase syndrome: 25 cases.
    Gusdorf L; Morruzzi C; Goetz J; Lipsker D; Sibilia J; Cribier B
    Ann Dermatol Venereol; 2019 Jan; 146(1):19-25. PubMed ID: 30595338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.